Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Kangtai Biological Products Co., Ltd.
  6. Summary
    300601   CNE100002Q33

SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

(300601)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
107.02 104.63 106.97 108.94 107.05 Last
8887537 5725439 3755738 4591227 4754637 Volume
+0.14% -2.23% +2.24% +1.84% -1.73% Change
Estimated financial data (e)
Sales 2021 3 490 M 542 M 542 M
Net income 2021 1 132 M 176 M 176 M
Net cash position 2021 3 448 M 536 M 536 M
P/E ratio 2021 64,4x
Yield 2021 0,25%
Sales 2022 5 604 M 871 M 871 M
Net income 2022 1 827 M 284 M 284 M
Net cash position 2022 3 238 M 503 M 503 M
P/E ratio 2022 39,2x
Yield 2022 0,42%
Capitalization 73 539 M 11 428 M 11 428 M
EV / Sales 2021 20,1x
EV / Sales 2022 12,5x
Nbr of Employees 2 043
Free-Float 96,9%
More Financials
Company
Shenzhen Kangtai Biological Products Co. specialises in the research, development and marketing of human vaccines. Products include vaccines against hepatitis B, haemophilus influenzae type B, measles and rubella. 
Sector
Pharmaceuticals
Calendar
10/22Earnings Release
More about the company
Ratings of Shenzhen Kangtai Biological Products Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
09/24Shenzhen Kangtai Biological Products Co., Ltd. Announces 2021 Interim Distribution Plan..
CI
09/16Shenzhen Kangtai Biological Products Co., Ltd. Approves Interim Cash Dividend for the F..
CI
09/08Shenzhen Kangtai Biological Products Co., Ltd. Announces Recombinant COVID-19 Vaccine (..
CI
08/30Shenzhen Kangtai Biological Products Co., Ltd. Proposes Cash Dividend for the First Hal..
CI
08/29Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
CI
08/02Shenzhen Kangtai Biological Products Co., Ltd. Announces Philippine Food and Drug Admin..
CI
07/13SHENZHEN KANGTAI BIOLOGICAL PRODUCTS : Kangtai Biological to Issue $309 Million Renminbi-D..
MT
06/22Phase III Clinical Fieldwork of the Inactivated COVID-19 Vaccine (Vero Cells) Independe..
CI
05/31SHENZHEN KANGTAI BIOLOGICAL PRODUCTS : Kangtai Biological to List 1.3 Million Newly Unlock..
MT
05/25China's Kangtai Biological, partners agree to run Phase III trial in Chile - Xinhua
RE
05/21Shenzhen Kangtai Biological Products Co., Ltd. Not to Pay Dividend for the Year 2020
CI
05/16SHENZHEN KANGTAI BIOLOGICAL PRODUCTS : China Approves Kangtai Biological's COVID-19 Vaccin..
MT
04/29Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Q..
CI
04/23Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Ye..
CI
02/02MARKET CHATTER : Kangtai Biological to Produce 400 Million AstraZeneca COVID-19 Vaccines A..
MT
More news
News in other languages on SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
09/24Shenzhen Kangtai Biological Products Co., Ltd. annonce la mise en œuvre du plan de dist..
09/16Shenzhen Kangtai Biological Products Co, Ltd. approuve le versement d'un dividende inté..
More news
Chart SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Shenzhen Kangtai Biological Products Co., Ltd. Technical Analysis Chart | 300601 | CNE100002Q33 | MarketScreener
Technical analysis trends SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 107,05 CNY
Average target price 204,43 CNY
Spread / Average Target 91,0%
EPS Revisions
Managers and Directors
Wei Min Du Chairman & General Manager
Xiang Miao Chief Financial Officer & Board Secretary
Zhi Yun Lu Chairman-Supervisory Board
Xiang Ming Li Independent Director
Dong Guang Ma Independent Director
Sector and Competitors